Medexpress Urgent Care, PC - Massachusetts
Medexpress Urgent Care, PC - Massachusetts was paid $4.72M by Medicaid between Jan 2018 and Nov 2024, across 23 billing codes. Its largest line is 99203, doctor's office visit, new patient (routine) — 31% of everything it billed.
SPRINGFIELD, MA 01128
Next to other Emergency Medicine Physician providers in Massachusetts
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,875 | $614K | |
| 2019 | 14,466 | $797K | |
| 2020 | 15,089 | $847K | |
| 2021 | 24,352 | $1.27M | |
| 2022 | 14,553 | $729K | |
| 2023 | 4,392 | $255K | |
| 2024incomplete | 3,191 | $200K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 31% | 18,954 | 18,920 | $1.48M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 17,698 | 17,326 | $1.30M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 20,046 | 19,467 | $1.11M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6.5% | 10,200 | 10,014 | $305K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.9% | 1,928 | 1,927 | $230K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2.6% | 1,945 | 1,941 | $120K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 4,262 | 4,224 | $50K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.0% | 3,945 | 2,080 | $49K |
| 99051 | <1% | 2,256 | 2,186 | $22K | |
| S9083 | Global fee urgent care centers | <1% | 109 | 101 | $16K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 309 | 307 | $12K |
| 81025 | <1% | 1,370 | 1,352 | $9K |
11 more codes
| 81003 | <1% | 2,940 | $6K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 308 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 140 | $3K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 66 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 75 | $1K |
| 90674 | <1% | 66 | $1K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 72 | $1K |
| 73630 | <1% | 12 | $235.97 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 162 | $0.78 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 43 | $0.16 |
| 87070 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.